3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Vaginal Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroendocrine Tumors
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Gallbladder Neoplasms
1
Blast Crisis
1
Interventions
fludarabine phosphate
22
Mycophenolic Acid
17
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
13
Cyclophosphamide
12
Cyclosporine
11
Tacrolimus
10
Cyclosporins
9
Antilymphocyte Serum
9
Busulfan
8
fludarabine
7
Rituximab
7
Sirolimus
5
Methotrexate
5
Melphalan
4
Filgrastim
3
Cytarabine
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
pegfilgrastim
2
ibrutinib
2
Thiotepa
2
Oxaliplatin
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Darbepoetin alfa
2
Clofarabine
2
selinexor
1
sargramostim
1
ofatumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
Clear all
No trials found.